Back
Ameriprise Financial Vs. Monopar Therapeutics Industry Stock Comparison
Buy
66
AMP
Ameriprise Financial
Last Price:
$485.71
Seasonality Move:
5.42%
Sell
33
MNPR
Monopar Therapeutics
Last Price:
$30.50
Seasonality Move:
-28.14%
Buy
66
Ameriprise Financial (AMP)
is a Buy
Is Ameriprise Financial a Buy, Sell or Hold?
-
The current Ameriprise Financial [AMP] share price is $485.83. The Score for AMP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AMP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $29.75. The Score for MNPR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMP Stock Price Chart
What is Ameriprise Financial's stock price today?
-
The Ameriprise Financial share price today is $485.83Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $29.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
AMP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -15.8 | Sell |
Relative Strength Index (14 RSI): | 36.74 | Sell |
Chaikin Money Flow: | 314290 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (498.11 - 543.95) | Sell |
Bollinger Bands (100): | (514.28 - 560.92) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.5 | Sell |
Relative Strength Index (14 RSI): | 41.36 | Sell |
Chaikin Money Flow: | -13348 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30 - 46.5) | Sell |
Bollinger Bands (100): | (15.79 - 38.07) | Buy |
AMP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 490.77 | Sell |
20-day SMA: | 517.46 | Sell |
50-day SMA: | 532 | Sell |
200-day SMA: | 488.17 | Sell |
8-day EMA: | 492.03 | Sell |
20-day EMA: | 510.13 | Sell |
50-day EMA: | 524.97 | Sell |
200-day EMA: | 493.51 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.17 | Sell |
20-day SMA: | 35.44 | Sell |
50-day SMA: | 34.91 | Sell |
200-day SMA: | 15.29 | Buy |
8-day EMA: | 30.66 | Sell |
20-day EMA: | 33.76 | Sell |
50-day EMA: | 33.32 | Sell |
200-day EMA: | 19.94 | Buy |
Ameriprise Financial Earnings Growth & AMP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.33 per share, an increase this year of $3.54 per share, and an increase next year of $3.71 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Ameriprise Financial Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |